L Ma1, Z Huang1, X-L Chen1, J Ma2, X-J Liu1, H Wang3, X Ye3, S-L Wang3, Y Cao4, S Wang4, Y-L Zhao5, J-Z Zhao6. 1. From the Departments of Neurosurgery (L.M., Z.H., X.-L.C., X.-J.L., H.W., X.Y., S.-L.W., Y.C., S.W., Y.-L.Z., J.-Z.Z.) China National Clinical Research Center for Neurological Diseases (L.M., Z.H., X.-L.C., X.-J.L., Y.C., S.W., Y.-L.Z., J.-Z.Z.), Beijing, P. R. China. 2. Neuroradiology (J.M.), Beijing Tiantan Hospital, Capital Medical University, Beijing, P. R. China. 3. From the Departments of Neurosurgery (L.M., Z.H., X.-L.C., X.-J.L., H.W., X.Y., S.-L.W., Y.C., S.W., Y.-L.Z., J.-Z.Z.). 4. From the Departments of Neurosurgery (L.M., Z.H., X.-L.C., X.-J.L., H.W., X.Y., S.-L.W., Y.C., S.W., Y.-L.Z., J.-Z.Z.) China National Clinical Research Center for Neurological Diseases (L.M., Z.H., X.-L.C., X.-J.L., Y.C., S.W., Y.-L.Z., J.-Z.Z.), Beijing, P. R. China Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease (Y.C., S.W., Y.-L.Z., J.-Z.Z.), Beijing, P. R. China. 5. From the Departments of Neurosurgery (L.M., Z.H., X.-L.C., X.-J.L., H.W., X.Y., S.-L.W., Y.C., S.W., Y.-L.Z., J.-Z.Z.) China National Clinical Research Center for Neurological Diseases (L.M., Z.H., X.-L.C., X.-J.L., Y.C., S.W., Y.-L.Z., J.-Z.Z.), Beijing, P. R. China Center for Stroke (Y.-L.Z., J.-Z.Z.), Beijing Institute for Brain Disorders, Beijing, P. R. China Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease (Y.C., S.W., Y.-L.Z., J.-Z.Z.), Beijing, P. R. China. zhaoyuanli@126.com. 6. From the Departments of Neurosurgery (L.M., Z.H., X.-L.C., X.-J.L., H.W., X.Y., S.-L.W., Y.C., S.W., Y.-L.Z., J.-Z.Z.) China National Clinical Research Center for Neurological Diseases (L.M., Z.H., X.-L.C., X.-J.L., Y.C., S.W., Y.-L.Z., J.-Z.Z.), Beijing, P. R. China Center for Stroke (Y.-L.Z., J.-Z.Z.), Beijing Institute for Brain Disorders, Beijing, P. R. China Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease (Y.C., S.W., Y.-L.Z., J.-Z.Z.), Beijing, P. R. China.
Abstract
BACKGROUND AND PURPOSE: The morphologic features of brain arteriovenous malformations differ between children and adults; therefore, our aim was to analyze various features of brain arteriovenous malformations to assess the risk of hemorrhage in children. MATERIALS AND METHODS: We identified all consecutive children admitted to Beijing Tiantan Hospital for brain arteriovenous malformations between July 2009 and April 2014. The effects of demographic characteristics and brain arteriovenous malformation morphology on hemorrhage presentation, annual bleeding rates, postnatal hemorrhage, and immediate posthemorrhagic neurologic outcomes were studied by using univariate and multivariable regression analyses. RESULTS: A total of 108 pediatric brain arteriovenous malformation cases were identified, 66 (61.1%) of which presented with hemorrhage. Of these, 69.7% of ruptured brain arteriovenous malformations were in a periventricular location. Periventricular nidus location (OR, 3.443; 95% CI, 1.328-8.926; P = .011) and nidus size (OR, 0.965; 95% CI, 0.941-0.989; P = .005) were independent predictors of hemorrhagic presentation. The annual hemorrhage rates in children with periventricular brain arteriovenous malformations were higher at 6.88% (OR, 1.965; 95% CI, 1.155-3.341; P < .05). The hemorrhage-free survival rates were also lower for children with periventricular brain arteriovenous malformations (log-rank, P = .01). Periventricular location (hazard ratio, 1.917; 95% CI, 1.131-3.250; P = .016) and nidus size (hazard ratio, 0.983; 95% CI, 0.969-0.997; P = .015) were associated with hemorrhage after birth in pediatric brain arteriovenous malformations. An ordinal analysis showed lower immediate posthemorrhage mRS in patients with periventricular brain arteriovenous malformations (OR for greater disability, 2.71; 95% CI, 1.03-7.11; P = .043). CONCLUSIONS: Small periventricular brain arteriovenous malformations were associated with increased hemorrhage risk in pediatric patients. Cautious follow-up of children with untreated periventricular brain arteriovenous malformations is recommended because of a higher hemorrhage risk and potentially more severe neurologic outcomes.
BACKGROUND AND PURPOSE: The morphologic features of brain arteriovenous malformations differ between children and adults; therefore, our aim was to analyze various features of brain arteriovenous malformations to assess the risk of hemorrhage in children. MATERIALS AND METHODS: We identified all consecutive children admitted to Beijing Tiantan Hospital for brain arteriovenous malformations between July 2009 and April 2014. The effects of demographic characteristics and brain arteriovenous malformation morphology on hemorrhage presentation, annual bleeding rates, postnatal hemorrhage, and immediate posthemorrhagic neurologic outcomes were studied by using univariate and multivariable regression analyses. RESULTS: A total of 108 pediatric brain arteriovenous malformation cases were identified, 66 (61.1%) of which presented with hemorrhage. Of these, 69.7% of ruptured brain arteriovenous malformations were in a periventricular location. Periventricular nidus location (OR, 3.443; 95% CI, 1.328-8.926; P = .011) and nidus size (OR, 0.965; 95% CI, 0.941-0.989; P = .005) were independent predictors of hemorrhagic presentation. The annual hemorrhage rates in children with periventricular brain arteriovenous malformations were higher at 6.88% (OR, 1.965; 95% CI, 1.155-3.341; P < .05). The hemorrhage-free survival rates were also lower for children with periventricular brain arteriovenous malformations (log-rank, P = .01). Periventricular location (hazard ratio, 1.917; 95% CI, 1.131-3.250; P = .016) and nidus size (hazard ratio, 0.983; 95% CI, 0.969-0.997; P = .015) were associated with hemorrhage after birth in pediatric brain arteriovenous malformations. An ordinal analysis showed lower immediate posthemorrhage mRS in patients with periventricular brain arteriovenous malformations (OR for greater disability, 2.71; 95% CI, 1.03-7.11; P = .043). CONCLUSIONS: Small periventricular brain arteriovenous malformations were associated with increased hemorrhage risk in pediatric patients. Cautious follow-up of children with untreated periventricular brain arteriovenous malformations is recommended because of a higher hemorrhage risk and potentially more severe neurologic outcomes.
Authors: C Stapf; H Mast; R R Sciacca; J H Choi; A V Khaw; E S Connolly; J Pile-Spellman; J P Mohr Journal: Neurology Date: 2006-05-09 Impact factor: 9.910
Authors: J F Meder; C Oppenheim; J Blustajn; F Nataf; L Merienne; D Lefkoupolos; A Laurent; J J Merland; M Schlienger; D Fredy Journal: AJNR Am J Neuroradiol Date: 1997-09 Impact factor: 3.825
Authors: Rustam Al-Shahi Salman; Philip M White; Carl E Counsell; Johann du Plessis; Janneke van Beijnum; Colin B Josephson; Tim Wilkinson; Catherine J Wedderburn; Zoe Chandy; E Jerome St George; Robin J Sellar; Charles P Warlow Journal: JAMA Date: 2014 Apr 23-30 Impact factor: 56.272
Authors: Ingrid Blom; Els L L M De Schryver; L Jaap Kappelle; Gabriël J E Rinkel; Aag Jennekens-Schinkel; A C Boudewyn Peters Journal: Dev Med Child Neurol Date: 2003-04 Impact factor: 5.449
Authors: Christopher P Kellner; Michael M McDowell; Michelle Q Phan; E Sander Connolly; Sean D Lavine; Philip M Meyers; Daniel Sahlein; Robert A Solomon; Neil A Feldstein; Richard C E Anderson Journal: J Neurosurg Pediatr Date: 2014-09-19 Impact factor: 2.375